Apimeds Pharmaceuticals US, Inc. (APUS): 3 insider purchases in the last two years.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| May 15, 2025 | Kim Christopher Director, Officer | 27,500 | $1.83 | $50.4K | no history |
| May 14, 2025 | Inscobee Inc. TenPercentOwner | 500,000 | $4.00 | $2.0M | no history |
| May 14, 2025 | Koo Jakap Director | 28,500 | $1.99 | $56.7K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.